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Background: The genetic diversity of Plasmodium falciparum has been extensively studied in various countries.
However, limited data are available from Ethiopia. This study was conducted to evaluate the extent of genetic
diversity of P. falciparum in Kolla-Shele, in the southwest of Ethiopia.
Methods: A total of 88 isolates from patients with uncomplicated P. falciparum attending Kolla-Shele Health Centre
was collected from September to December, 2008. After extraction of DNA by Chelex® method, the samples were
genotyped by using nested-PCR of msp1 (block 2) and msp2 (block 3) including their allelic families: K1, MAD20,
RO33 and FC27, 3D7/IC1, respectively.
Results: Allelic variation in both msp1 and msp2 were identified in the 88 blood samples. For msp1 67% (59/88)
and msp2 44% (39/88) were observed. K1 was the predominant msp1 allelic family observed in 33.9% (20/59) of the
samples followed by RO33 and MAD20. Of the msp2 allelic family 3D7/IC1 showed higher frequency (21.5%)
compared to FC27 (10.3%). A total of twenty-three alleles were detected; of which, eleven were from msp2 and
twelve from msp2 genes. Fifty-nine percent of isolates had multiple genotypes and the overall mean multiplicity of
infection was 1.8 (95% CI: 1.48-2.04). The heterozygosity index was 0.79 and 0.54for msp1 and msp2, respectively.
There was no statically significant difference in the multiplicity of infection by either age or parasite density (P > 0.05).
Conclusion: This genetic diversity study showed the presence of five allelic types in the study area, with dominance K1
in the msp1 family and 3D7/IC1 in the msp2 family. Multiple infections were observed in nearly 60% of the samples.Background
Malaria, a disease mostly caused by Plasmodium falciparum,
is a major public health problem. The global burden is
207 million malaria cases every year resulting into
627,000 deaths [1], sub-Saharan Africa being the most
affected region. In Ethiopia, malaria still remains a
major health problem with about two-thirds of the
population living in malarious areas [2]. Among the
malaria parasites, P. falciparum is the most fatal species,
and exhibits complex genetic polymorphism which may
explain its ability to develop multiple drug resistance and
circumvent vaccines [3].* Correspondence: hussein_ehnri@yahoo.com
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unless otherwise stated.Recent, studies of anti-malarial drug resistance in Ethiopia
have confirmed high level of resistance to sulphadoxine-
pyrimethamine. Consequently, in 2004, Ethiopia changed its
anti-malarial drug policy to artemisinin-based combination
therapy (ACT) Coartem® as first-line drug for the treatment
of uncomplicated falciparum malaria [4,5]. Following this,
in 2005, the country launched a scaling up of its control and
prevention programme with strategies that lead towards
malaria elimination in the country [6]. However, since, there
is lack of pre-elimination data of malaria parasite population
circulating in the country, it was found important to study
the genetic diversity, using the two highly polymorphic
markers, merozoite surface protein 1 and merozoite surface
protein 2.
Merozoite surface protein 1 and 2 of P. falciparum are
major blood-stage malaria vaccine targets [7] and are
also suitable markers for the identification of geneticallyntral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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major surface protein of approximately 190-kDa size. It
plays a major role in erythrocyte invasion [8] and is a
major target of immune responses [9]. MSP1 contains
17 blocks of sequence flanked by conserved regions [10]
Block 2, which is the most polymorphic part of MSP1, is
grouped into three allelic families namely K1, MDA20,
and RO33 type [11]. MSP2 is glycoprotein consisting five
blocks where the central block is the most polymorphic
[12]. MSP2 alleles are grouped into two allelic families,
FC27 and 3D7/IC1.
Based on the literature, there is no published data
available on the diversity and multiplicity of infection in
uncomplicated falciparum malaria in the country. Such
data have importance in documenting the parasite genetic
diversity changes due to elimination pressure through the
scaled up malaria control intervention. This study was
under taken to collect background data on the extent gen-
etic diversity of P. falciparum in the pre-elimination
period from Kolla-Shele in southwestern Ethiopia.Methods
Study area
The study was conducted in Kolla-Shele area, Arbaminch
Zuria District, southern Ethiopia. Where malaria transmissionFigure 1 Map of study area, Kolla-Shele in southern Ethiopia (Source:is highly seasonal and markedly unstable. The study
area is located about 27 kms from Arbaminch town
and 532 kms from Addis Ababa. Kolla Shele is one of
the kebeles of Arbaminch Zuria ditrict, with a catch-
ment population of 47,044 inhabitants (Figure 1) [13].
This area lies between 1,250 and 1,400 metres above
sea level (asl). The study area has an entomological in-
oculation rate (EIR) of 17.1 infectious bites per person
per year [14]. Plasmodium falciparum is the predomin-
ant parasite species and Anopheles arabiensis is the
major vector.Study population and blood sample collection
A total of 88 P. falciparum blood spotted samples were
collected from patients aged six months to twenty years,
who visited the health centre during the evaluation of a
therapeutic efficacy study, September-December, 2008
[15]. The patients who were febrile, with an axillary
temperature ≥37.5°C, were positive for asexual P. falcip-
arum, and were residents within the catchment area (i.e.
5–10 km radius of the health centre) were enrolled if
they consented, in accordance with the inclusion criteria
[16]. Finger prick blood samples were collected on day 0
when patients were enrolled in the study. The blood was
spotted onto filter paper (Whatman® 927 mm), air-dried[13]).
Table 1 Demographic characteristics of the study subjects
at Kolla-Shelle Health Centre, Arbaminch Zuria District,
southwest Ethiopia (n = 88)
Characteristics of patients Values
Mean age 7.47 ± 5.3
Age range 6 months to 20 years
Sex ratio ( M/F) 1.1 (45/43)
Geometric mean parasitaemia (parasites/μl) 7,701.5 (5839.9-10156.4).
Parasite density range 1000 to 100,000
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lecular Laboratory of the Ethiopian Public Health Insti-
tute (EPHI).
Extraction of parasite DNA
Genomic DNA was extracted from the stored dried blood
spots (collected on Day0) using Chelex-100® (Bio-Rad
Laboratories CA) method [17], giving a final volume of
200 μl for each sample. All parasites DNA extracted
were stored at -20°C until used for the amplification
reaction.
Allelic typing of Plasmodium falciparum msp1 and msp2
genes
All samples were genotyped for P. falciparum using the
nested polymerase chain reactions (PCRs) technique
[18]. All reactions were carried out in a final volume of
25 μl containing 20 mM dNTP, 10 μM of each primer,
and 1 unit /25 ul reaction volume of Taq DNA polymer-
ase (Roche Applied Science, Germany). In the first
round reaction, 4 μl of genomic DNA was added as a
template. In the nested reaction, 2 μl of the first PCR
product was added. Each amplification profile consisted
of initial denaturation at 94°C for 3 minutes, followed
immediately by 30 cycles at 94°C for 1 min; 50°C for
35 seconds, and 68°C for 2.5 minutes. The final cycle
had a prolonged extension at 72°C for 3 minutes. PCR
reaction mixtures were incubated in a thermal cycler
(MyCycler-BioRad, Hercules, USA). Allelic specific posi-
tive control 3D7 and DNA-free negative controls were
included in each set of reaction [19]. Gel photographs
were re-scored by visual comparison of DNA fragments
and for individual samples, alleles were identified ac-
cording to band size [Additional file 1: Figure S1]. The
size of the PCR products was estimated using 100 bp
DNA ladder marker (Boehringer Mannheim Marker VI).
The size polymorphism in each allelic family was analysed,
assuming that one band represented one amplified PCR
fragment derived from a single copy of P. falciparum
msp-1 or msp-2 genes. Alleles in each family were con-
sidered the same if fragment sizes were within 20 bp
interval [20]. The heterozygosity index (He), was calcu-
lated by using the following formula: He = [n/(n-1)]
[(1-Σpi2 )], where n is the number of isolates sampled
and pi is the allele frequency at a given locus [21].
Data analysis
Data were entered and analysed using SPSS version 16
(SPSS Inc., Chicago, IL, USA). The msp1 and msp2 al-
lelic frequency was calculated as the proportion of the
allele found for the allelic family out of the alleles de-
tected in the isolates. The number of samples with more
than one amplified fragment within total samples is de-
fined as frequency of polyclonal infection. The meanmultiplicity of infection (MOI) was calculated as a total
number of P. falciparum genotype detected per total
number of positive samples. The Chi-square test was
used to compare MOI with the event of a previous mal-
aria attack. Spearman’s rank correlation coefficient was
calculated to assess association between MOI and para-
site density and age. Statistical significance was defined
as P value ≤ 0.05.
Ethical clearance
The study was ethically approved by the Institutional
Review Board (IRB) of Department of Medical Laboratory
Science Addis Ababa University. In addition, Scientific
and Ethical approval was obtained from Scientific and
Ethical Review Office (SERO) of the Ethiopian Public
Health Institute (EPHI).
Results
Demographic and parasitological data
The characteristics of the study populations are detailed
in Table 1. The patients ages ranged from six months to
20 years (mean age: 7.5 years). The geometric mean
parasite density was 7,702 (95% CI: 5839.9-10156.4) par-
asites/μl of blood with a range of 1,000 to 100,000 para-
sites/ μl. The parasite DNA from the 88 P. falciparum
isolates was analysed for msp1 and msp2 genes. The esti-
mated of frequency of msp-1 and msp-2 gene amplifi-
cation reactions with family specific primers was 67%
(59/88) and 44% (39/88), respectively.
Allelic diversity of Plasmodium falciparum msp1 and msp2
genes
Length polymorphism was assessed in 88 P. falciparum
isolates within the allelic families of msp1 and msp2 with
a total of 155 distinct fragments detected. This allele
typing analysis displayed the highly polymorphic nature
of P. falciparum in Kolla-Shele isolates with respect to
msp1. In msp1, K1, RO33 and MAD20 allele types were
identified. Frequencies of different msp-1 alleles and
their combinations and multiplicity of infection are
shown in Tables 2 and 3.
The proportion of K1, MAD20 and RO33 types were
33.9%, 8.5% and 15.2%, respectively. The remaining nearly
Table 2 Allele typing and diversity profiles of Plasmodium
falciparum isolates from Southwest Ethiopia based on
genetic diversity of msp1 and msp2, Koll-Shele area
Southwest Ethiopia, 2014
Allelic type n (%) Allelic type n (%)
MSP-1 MSP-2
K1 20(33.9) FC27 4(10.3)
MAD20 5(8.5) 3D7/IC1 8(21.5)
RO33 9(15.2) FC27 + 3D7/IC1 27(69.2)
RO33 + K1 15(25.4)
K1 + MAD20 3(5.1)
RO33 +MAD20 2(3.4)
Mad20 + K1 + Ro33 5(8.5)
Total 59 39
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K1/RO33, MAD20/RO33 and K1/MAD20/RO33). The
monoclonal infections were 34 (57.6%). Among Polyclonal
infections those that carried two allelic types K1/RO33, K1/
MAD20, MAD20/RO33 comprised 25.4%, 5.1% and 3.4%,
respectively. Trimorphic infections K1/MAD20/RO33were
detected in 8.5% of cases (Table 2).
A total of 23 individual msp alleles were identified (11
for msp1 and 12 for msp2). Among msp1 isolated, three
for K1 (200–250 bp), five for RO33 (150–225 bp) and
three for MAD20 (100-300 bp) allele families were ob-
served (Table 3). With respect to msp2, both FC27and
3D7/IC1 allele types were detected. The frequency of
samples having only 3D7/IC1 allelic family (21.5% (8/39))
was higher than the sample with only FC27 allelic type
(10.3% (4/39)). Twenty-seven of the isolated (69.2%) car-
ried both msp2 allelic families (Table 2). On the other
hand, among cases that were positive for msp2 alleles,
31% (12/39) were monoclonal infection while 69.2%
(27/39) were polyclonal infections. The length variants
of the amplified products were seven for FC27 (300–
600 bp) and five for 3D7/IC1 (200–500 bp) (Table 3).Table 3 Plasmodium falciparum genotypes and base pair
ranges observed in msp1 and msp2, as well as their
respective allelic families, Koll-Shele area, Southwest
Ethiopia, 2014
msp-1 msp-2
K1 MAD20 RO33 FC27 3D7/IC1
Base pair range 200-250 100–300 150-225 300-600 200- 500






1.7 1.6Overall, the mean multiplicity of infection was 1.8
(95% CI: 1.48-2.04). Out of the 88 samples, 52 (59%)
harbored more than one parasite genotype. When con-
sidering msp1and msp2 genes separately, the overall
multiplicity of infection was 1.7 and 1.6, respectively.
The heterozygosity index, which represents the probabil-
ity of being infected by two parasites with different al-
leles at a given locus, was 0.79 for msp1 and 0.54 for
msp2 loci.
A statistically significant correlation between previous
malaria attack and MOI was observed (P = 0.00), but not
non-expose malaria (Figure 2). Neither there was any
significant correlation between multiplicity of infection
and parasite density of patients (Spearman rank coeffi-
cient = 0.03; P = 0.8) (Figure 3).
Discussion
In Ethiopia, less attention has been given to investigating
the genetic diversity of P. falciparum than other coun-
tries. This is the first MSP based study to provide infor-
mation about the genetic diversity of P. falciparum in
Ethiopia. These finding may be an important element
for implementing malaria control strategies in the coun-
try, as elimination may influence genetic diversity and
their heterozygosity.
The allele specific P. falciparum msp1 and msp2 geno-
typing has shown that malaria parasite population in
Kolla-Shele area is moderate to high allelic diversity.
However, the number of alleles may have been underes-
timated due to the limitation of the technique. Indeed,
fragments with the length interval of less than 20 bp
could not clearly be distinguished as a separate allele. In
their allelic frequency, out of the 59 allelic types detected
in msp1, the K1 allelic family with 33.9% allelic fre-
quency besides its representation in poly allelic bands,
was found predominant This is in line with previous
studies in Central Africa, Gabon, Benin, and Ghana
[18,22-24], but in contrast to studies from Sudan and
Malaysia where RO33 allele was predominant [25,26].
With regard to msp2, 39 allelic types were found and the
alleles belonging to 3D7/IC1 family were more frequently
detected (21.5%). This is similar to data reported from
Kenya, Congo Brazzaville and other sub-Saharan-African
countries [10,20,27], as well as Peru and Iran [28,29].
The entomologic inoculation rate (EIR) study conducted
in the same region showed a value of 17.1 infectious bites
per person per year [14], the moderate to high EIR value
reported shows the meso-endemicity of malaria transmis-
sion which is in agreement with this finding of moderately
high genetic polymorphism of 60% and MOI of 1.8. It is
reported that the multiplicity of infection in an infected
patient may be due to an important entomological inocu-
lation rate as shown in the Senegal where patients are ex-
posed to a large number of infective bites [30].
Figure 2 Comparison of MOI and parasite density against previous malaria attack in Kolla-Shell, Southwest Ethiopia.
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for msp1 (0.79), indicating a larger genotype diversity
within the msp1 locus than that of msp2, with He 0.54,
which is nearly 0.5, i.e. the maximum expected Nei di-
versity index for allelic locus. This is almost parallel to
the Hardy Weinberg’s 0.5 “2pq” equilibrium heterozy-
gosity, in equal frequency P and q alleles. Similarly a
moderate heterozygosity level of 0.51 < He 1998-1999-
2002 < 0.58 was observed in the population diversity of
P. falciparum in Djibouti [31]. This, however, indicates
only the state of equilibrium heterozygosity at the
microsatellite loci, which by 2009 reached a state of
total similarity, He = 0, indicating the monoclonality
of the Djibouti strain at the studied loci. What will be
found in the future with the process of elimination
peaking pace in Ethiopia remains to be observed, es-
pecially with the highly divergent allelic locus of
msp1.Figure 3 Relationship between mean parasite density and multiplicityThe predominant families in the msp-1 and msp-2
were K1 and 3D7/IC1, respectively, indicating that both
K1 and 3D7/IC1 are good indicators for determination
of MOI, at least in Southern Ethiopia. This is because
high numbers of bands were encountered with geno-
types of these two allelic families. These findings are in
agreement with previous study in Republic of Congo
[20]. But it is in contrast to studies in Uganda and the
Sudan [25,32] where RO33and FC27 allelic families were
found predominant.
The FC27 fragment of 400 bp, which was the most
prevalent in clinical episodes of malaria among symp-
tomatic malaria children, similar observations were re-
ported from the Republic of Congo and Burkina Faso
[33,34]. This may indicate an association between this
FC27 allelic type and clinical episode.
This study also showed that the number of parasite ge-
notypes carried by subjects with symptomatic infectionsof infection (n = 88).
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previous reports in Republic of Congo and Gabon
[20,22]. This may be besides PCR limitations, possibly
other factors like comparable level of immune naivety of
young and older children in the sample population not
to selectively “weed out” certain circulating genotypes.
The MOI values reported in this study was higher than
found in countries like Malaysia where the multiplicity
of P. falciparum infection was 1.37 and 1.20 for msp1
and msp2, respectively [26]. but lower from findings in
Côte d’Ivoire, where their MOI was found to be 2.88
msp2 [35]. This discrepancy may be due to differences in
geographical areas and their transmission patterns (dif-
fering malaria endemicity level) and also due to differ-
ences in sample population determination. Generally,
however, the higher the malaria transmission level, the
greater becomes the tendency to get a higher MOI and
mean number of alleles per locus. Thus in neighbouring
Djibouti, P. falciparum genetic diversity study showed a
decrease of MOI from 1.42 at the peak transmission year
in 1999 to 1.12 in 2002 and just 1.0, in 2009, the time
the control programme advanced in its pre-elimination
phase. With 1.8 MOI, this is nearly two alleles per locus
and parallel to this polyclonality, as explained above is
observed a moderate (msp2) to high (msp1) He values.
The present study found that about two-third of the sam-
ples (59%) harboured multiple genotypes; almost similar fre-
quency (62%) to that in the Sudan [25], while 83% of the
sample population harboured multiple genotypes, in the Re-
public of Congo [20]. This may go with unstable seasonality
of transmission in most malarious areas of Ethiopia, which is
more similar with the Sudan than that of West Africa.
The mean MOI of persons with previous exposure to
malaria attack is higher compared to persons with absence
of previous malaria attack (non-exposed) i.e. high frequency
of MOI correlates with high frequency of parasitic density.
The finding may indicate that persons with lower parasitic
density may have low acquired immunity (higher risk of
clinical malaria), that they become symptomatic at a lower
parasite threshold, unlike those with previous exposures.
This is a tacit indicator that just few previous exposures, can
elicit certain level of clinical immunity to make them toler-
ant to lower parasitaemic threshold up to 10,000Ps/ul blood.
This study represents a first attempt to analyse the
molecular characteristic of P. falciparum population.
However, future study needs to be designed to increase
the representative sample sizes in different transmission
areas and use more robust techniques, such as microsat-
ellite DNA sequencing, to study in depth the molecular
diversity of the P. falciparum parasite.
Conclusion
The results of this study showed genetic diversity and al-
lelic distribution in msp1 and msp2 in P. falciparumisolates from Kolla-Shelle area. The change in HE and
MOI could be potential useful parameters in the evalu-
ation of intervention against malaria, but this needs fur-
ther studies in several parts of the country, to examine
the allelic dominances and the dynamism of spatial/peri-
odic changes in the genetic diversity of P. falciparum in
Ethiopia.
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